Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jong-Heon Kim, Ruqayya Afridi, Won-Ha Lee & Kyoungho Suk. (2023) Analyzing the glial proteome in Alzheimer’s disease. Expert Review of Proteomics 20:10, pages 197-209.
Read now
Read now
Filippo Baldacci, Simone Lista, Giovanni Palermo, Filippo Sean Giorgi, Andrea Vergallo & Harald Hampel. (2019) The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development. Expert Review of Proteomics 16:7, pages 593-600.
Read now
Read now
Articles from other publishers (66)
Sumit Sarkar, Nikita Das & Kumar Sambamurti. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
511
525
.
Yannick van Sleen, Sudarshan A. Shetty, Marieke van der Heiden, Milou C. A. Venema, Nicolas Gutiérrez-Melo, Erik J. M. Toonen, Josine van Beek, Anne-Marie Buisman, Debbie van Baarle & Delphine Sauce. (2023) Frailty is related to serum inflammageing markers: results from the VITAL study. Immunity & Ageing 20:1.
Crossref
Crossref
Huiwen Zheng, Qianmin Chen, Jingyue Zhang, Baiqing Ren, Tianya Liu, Chao Liu, Xiaoye Wang, Jingyi Sheng & Zhiping Wang. (2023) Postoperative serum CHI3L1 level is associated with postoperative cognitive dysfunction in elderly patients after hip fracture surgery: A prospective observational study. Heliyon 9:8, pages e18796.
Crossref
Crossref
Chiara Milano, Domeniko Hoxhaj, Marta Del Chicca, Alessia Pascazio, Davide Paoli, Luca Tommasini, Andrea Vergallo, Chiara Pizzanelli, Gloria Tognoni, Angelo Nuti, Roberto Ceravolo, Gabriele Siciliano, Harald Hampel & Filippo Baldacci. (2023) Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers. Journal of Alzheimer's Disease 94:2, pages 611-625.
Crossref
Crossref
Lauren M. Forgrave, Kyung‐Mee Moon, Jordan E. Hamden, Yun Li, Phoebe Lu, Leonard J. Foster, Ian R. A. Mackenzie & Mari L. DeMarco. (2023) Truncated TDP‐43 proteoforms diagnostic of frontotemporal dementia with TDP‐43 pathology. Alzheimer's & Dementia.
Crossref
Crossref
Linbin Dai, Feng Gao, Qiong Wang, Xinyi Lv, Zhaozhao Cheng, Yan Wu, Xianliang Chai, Henrik Zetterberg, Kaj Blennow, Allan I Levey, Jiong Shi & Yong Shen. (2023) Molecules of senescent glial cells differentiate Alzheimer’s disease from ageing. Journal of Neurology, Neurosurgery & Psychiatry 94:7, pages 550-559.
Crossref
Crossref
Fei Li, An Liu, Minggao Zhao & Lanxin Luo. (2023) Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives. Journal of Neurochemistry 165:6, pages 772-790.
Crossref
Crossref
Wei Zhang, Xia Zhou, Jiabin Yin, Wenming Zhao, Chaojuan Huang, Cun Zhang, Ke Wan, Mingxu Li, Xiaoqun Zhu & Zhongwu Sun. (2023) YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease. Brain Research 1807, pages 148318.
Crossref
Crossref
D. Gouilly, M. Rafiq, L. Nogueira, A.-S. Salabert, P. Payoux, P. Péran & J. Pariente. (2023) Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology. Revue Neurologique.
Crossref
Crossref
Yang Li, Zuolong Chen, Qiong Wang, Xinyi Lv, Zhaozhao Cheng, Yan Wu, Fang Tang, Yong Shen & Feng Gao. (2022) Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer’s disease by integrated bioinformatics. Journal of Neurology 270:3, pages 1487-1500.
Crossref
Crossref
Nongthombam Boby, Apurv Srivastav, Sudesh K. Srivastav & Bapi Pahar. (2023) Divergent Cytokine and Chemokine Responses at Early Acute Simian Immunodeficiency Virus Infection Correlated with Virus Replication and CD4 T Cell Loss in a Rhesus Macaque Model. Vaccines 11:2, pages 264.
Crossref
Crossref
Poonam Sharma, Princi Thapak, Bhawana Chandwani, Harsha Kharkwal, G. T. Kulkarni, Rajendra Awasthi & Bhupesh Sharma. 2023. Deciphering Drug Targets for Alzheimer’s Disease. Deciphering Drug Targets for Alzheimer’s Disease
125
149
.
Samantha Prins, Marieke L. de Kam, Charlotte E. Teunissen & Geert Jan Groeneveld. (2022) Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease. Alzheimer's Research & Therapy 14:1.
Crossref
Crossref
Tiziana Alberio, Martina Brughera & Marta Lualdi. (2022) Current Insights on Neurodegeneration by the Italian Proteomics Community. Biomedicines 10:9, pages 2297.
Crossref
Crossref
Daniella Castro Araújo, Adriano Alonso Veloso, Karina Braga Gomes, Leonardo Cruz de Souza, Nivio Ziviani & Paulo Caramelli. (2022) A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer’s Disease. Journal of Alzheimer's Disease 88:2, pages 549-561.
Crossref
Crossref
Fernando Cavalcanti, Elena Gonzalez-Rey, Mario Delgado, Clara P. Falo, Leyre Mestre, Carmen Guaza, Francisco O’Valle, Michele M. P. Lufino, Jordi Xaus, Cristina Mascaró, Serena Lunardi, Natalia Sacilotto, Paola Dessanti, David Rotllant, Xavier Navarro, Mireia Herrando-Grabulosa, Carlos Buesa & Tamara Maes. (2022) Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis. Pharmaceutics 14:7, pages 1420.
Crossref
Crossref
Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Crossref
Oleg V. Dolotov, Ludmila S. Inozemtseva, Nikolay F. Myasoedov & Igor A. Grivennikov. (2022) Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes. International Journal of Molecular Sciences 23:9, pages 4999.
Crossref
Crossref
Linda Giampietri, Elisabetta Belli, Maria Francesca Beatino, Sara Giannoni, Giovanni Palermo, Nicole Campese, Gloria Tognoni, Gabriele Siciliano, Roberto Ceravolo, Ciro De Luca & Filippo Baldacci. (2022) Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments. Diagnostics 12:4, pages 796.
Crossref
Crossref
Münteha Nur Sonuç Karaboğa & Mustafa Kemal Sezgintürk. (2022) Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future. Journal of Pharmaceutical and Biomedical Analysis 209, pages 114479.
Crossref
Crossref
Yuehan Hao, Xu Liu & Ruixia Zhu. (2022) Neurodegeneration and Glial Activation Related CSF Biomarker as the Diagnosis
of Alzheimer’s Disease: A Systematic Review and an Updated Meta-
analysis. Current Alzheimer Research 19:1, pages 32-46.
Crossref
Crossref
Xuezhi Zhang, Wenwen Yu, Xuelei Cao, Yongbin Wang, Chao Zhu & Jialiang Guan. (2022) Identification of Serum Biomarkers in Patients with Alzheimer’s Disease by 2D-DIGE Proteomics. Gerontology 68:6, pages 686-698.
Crossref
Crossref
Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna‐Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, André Fischer, Michael P. Menden & Paul Lingor. (2022) Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease. Clinical and Translational Medicine 12:1.
Crossref
Crossref
Ioannis Mavroudis, Rumana Chowdhury, Foivos Petridis, Eleni Karantali, Symela Chatzikonstantinou, Ioana Miruna Balmus, Iuliana Simona Luca, Alin Ciobica & Dimitrios Kazis. (2021) YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease. Medicina 58:1, pages 60.
Crossref
Crossref
Joana B Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Charlotte E Teunissen, Henrik Zetterberg, Erik Stomrud, Nicholas J Ashton, Kaj Blennow & Oskar Hansson. (2021) Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease. Brain 144:11, pages 3505-3516.
Crossref
Crossref
Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen & Marcel M. Verbeek. (2021) Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alzheimer's Research & Therapy 13:1.
Crossref
Crossref
Krzysztof Laudanski, Aleksandra Yakhkind, Mariana Restrepo, Lindsay Draham & Adam Edward Lang. (2021) Guillain–Barré Syndrome in COVID-19—The Potential Role of NCAM-1 and Immunotherapy. BioMed 1:1, pages 80-92.
Crossref
Crossref
Vincent Marcucci & Jeremy Kleiman. (2021) Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review. Exploratory Research and Hypothesis in Medicine 000:000, pages 000-000.
Crossref
Crossref
Roberta Cascella & Cristina Cecchi. (2021) Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis. International Journal of Molecular Sciences 22:9, pages 4914.
Crossref
Crossref
Laura Cubas-NúñezSara Gil-Perotín, Jéssica Castillo-VillalbaVerónica LópezLuis Solís TarazonaRaquel Gasqué-RubioSara Carratalá-BoscáCarmen Alcalá-VicenteFrancisco Pérez-Miralles, Hans LassmannBonaventura Casanova. (2021) Potential Role of CHI3L1+ Astrocytes in Progression in MS. Neurology Neuroimmunology & Neuroinflammation 8:3.
Crossref
Crossref
Amanda Cano, Patric Turowski, Miren Ettcheto, Jason Thomas Duskey, Giovanni Tosi, Elena Sánchez-López, Maria Luisa García, Antonio Camins, Eliana B. Souto, Agustín Ruiz, Marta Marquié & Mercè Boada. (2021) Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Tamara G. Fong, Noel Y. Chan, Simon T. Dillon, Wenxiao Zhou, Bridget Tripp, Long H. Ngo, Hasan H. Otu, Sharon K. Inouye, Sarinnapha M. Vasunilashorn, Zara Cooper, Zhongcong Xie, Edward R. Marcantonio & Towia A. Libermann. (2021) Identification of Plasma Proteome Signatures Associated With Surgery Using SOMAscan. Annals of Surgery 273:4, pages 732-742.
Crossref
Crossref
Fangda Leng & Paul Edison. (2020) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?. Nature Reviews Neurology 17:3, pages 157-172.
Crossref
Crossref
Harald Hampel, Andrea Vergallo, Filippo Caraci, A. Claudio Cuello, Pablo Lemercier, Bruno Vellas, Kelly Virecoulon Giudici, Filippo Baldacci, Britta Hänisch, Marion Haberkamp, Karl Broich, Robert Nisticò, Enzo Emanuele, Francisco Llavero, José L. Zugaza, Alejandro Lucía, Ezio Giacobini & Simone Lista. (2021) Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery. Neuropharmacology 185, pages 108081.
Crossref
Crossref
André S. L. M. Antunes, Valéria de Almeida, Fernanda Crunfli, Victor C. Carregari & Daniel Martins-de-Souza. 2021. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
251
264
.
A. Abdelhak, A. Huss, A. Brück, U. Sebert, B. Mayer, H. P. Müller, H. Tumani, M. Otto, D. Yilmazer-Hanke, A. C. Ludolph, J. Kassubek, E. Pinkhardt & H. Neugebauer. (2020) Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease. Neurological Research and Practice 2:1.
Crossref
Crossref
Andrea Vergallo, Simone Lista, Pablo Lemercier, Patrizia A. Chiesa, Henrik Zetterberg, Kaj Blennow, Marie-Claude Potier, Marie-Odile Habert, Filippo Baldacci, Enrica Cavedo, Filippo Caraci, Bruno Dubois, Harald Hampel, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, Laurie Boukadida, Nadia Boukerrou, Enrica Cavedo, Patrizia Chiesa, Olivier Colliot, Bruno Dubois, Marion Dubois, Stéphane Epelbaum, Geoffroy Gagliardi, Remy Genthon, Marie-Odile Habert, Harald Hampel, Marion Houot, Aurélie Kas, Foudil Lamari, Marcel Levy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie-Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo, Nadjia Younsi, Mohammad Afshar, Lisi Flores Aguilar, Leyla Akman-Anderson, Joaquín Arenas, Jesús Ávila, Claudio Babiloni, Filippo Baldacci, Richard Batrla, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, Francesco Cacciola, Filippo Caraci, Giuseppe Caruso, Juan Castrillo†Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Massimo Corbo, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Enzo Emanuele, Valentina Escott-Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Hugo Geerts, Ezio Giacobini, Filippo S. Giorgi, Edward J. Goetzl, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Britta Hänisch, Harald Hampel, Karl Herholz, Felix Hernandez, Bruno P. Imbimbo, Dimitrios Kapogiannis, Eric Karran, Steven J. Kiddle, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Todd Langevin, Stéphane Lehéricy, Pablo Lemercier, Simone Lista, Francisco Llavero, Jean Lorenceau, Alejandro Lucía, Dalila Mango, Mark Mapstone, Christian Neri, Robert Nisticò, Sid E. O’bryant, Giovanni Palermo, George Perry, Craig Ritchie, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Pedro L. Valenzuela, Bruno Vellas, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Kelly Virecoulon Giudici, Mark Watling, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi & José L. Zugaza. (2020) Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers. Neurobiology of Aging 96, pages 22-32.
Crossref
Crossref
Eleonora Del Prete, Maria Francesca Beatino, Nicole Campese, Linda Giampietri, Gabriele Siciliano, Roberto Ceravolo & Filippo Baldacci. (2020) Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach. Journal of Personalized Medicine 10:4, pages 221.
Crossref
Crossref
Ting Zhao, Zhongping Su, Yingchang Li, Xiaoren Zhang & Qiang You. (2020) Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Ane-Victoria Idland, Roser Sala-Llonch, Leiv Otto Watne, Anne Brækhus, Oskar Hansson, Kaj Blennow, Henrik Zetterberg, Øystein Sørensen, Kristine Beate Walhovd, Torgeir Bruun Wyller & Anders Martin Fjell. (2020) Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults. Neurobiology of Aging 93, pages 1-15.
Crossref
Crossref
Jakob M Bader, Philipp E Geyer, Johannes B Müller, Maximilian T Strauss, Manja Koch, Frank Leypoldt, Peter Koertvelyessy, Daniel Bittner, Carola G Schipke, Enise I Incesoy, Oliver Peters, Nikolaus Deigendesch, Mikael Simons, Majken K Jensen, Henrik Zetterberg & Matthias Mann. (2020) Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease. Molecular Systems Biology 16:6.
Crossref
Crossref
Piotr Lewczuk, Marta Łukaszewicz-Zając, Piotr Mroczko & Johannes Kornhuber. (2020) Clinical significance of fluid biomarkers in Alzheimer’s Disease. Pharmacological Reports 72:3, pages 528-542.
Crossref
Crossref
Meng Lian, Hongbao Cao, Ancha Baranova, Kamil Kural, Lizhen Hou, Shizhi He, Qing Shao & Jugao Fang. (2020) Aging‑associated genes TNFRSF12A and CHI3L1 contribute to thyroid cancer: An evidence for the involvement of hypoxia as a driver. Oncology Letters.
Crossref
Crossref
Patrizia A. Chiesa, Marion Houot, Andrea Vergallo, Enrica Cavedo, Simone Lista, Marie Claude Potier, Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen, Ann De Vos, Bruno Dubois & Harald Hampel. (2020) Association of brain network dynamics with plasma biomarkers in subjective memory complainers. Neurobiology of Aging 88, pages 83-90.
Crossref
Crossref
Harald Hampel, Filippo Caraci, A. Claudio Cuello, Giuseppe Caruso, Robert Nisticò, Massimo Corbo, Filippo Baldacci, Nicola Toschi, Francesco Garaci, Patrizia A. Chiesa, Steven R. Verdooner, Leyla Akman-Anderson, Félix Hernández, Jesús Ávila, Enzo Emanuele, Pedro L. Valenzuela, Alejandro Lucía, Mark Watling, Bruno P. Imbimbo, Andrea Vergallo & Simone Lista. (2020) A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease. Frontiers in Immunology 11.
Crossref
Crossref
Richard M. Tsai, Zachary Miller, Mary Koestler, Julio C. Rojas, Peter A. Ljubenkov, Howard J. Rosen, Gil D. Rabinovici, Anne M. Fagan, Yann Cobigo, Jesse A. Brown, Joo In Jung, Emma Hare, David S. Geldmacher, Marissa Natelson-Love, Emily C. McKinley, Phi N. Luong, Emmeline L. Chuu, Ryan Powers, Paige Mumford, Amy Wolf, Ping Wang, Merhdad Shamloo, Bruce L. Miller, Erik D. Roberson & Adam L. Boxer. (2020) Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome. JAMA Neurology 77:2, pages 215.
Crossref
Crossref
Shou-Chao Wei, Wei Wei, Wan-Juan Peng, Zhou Liu, Zhi-You Cai & Bin Zhao. (2020) Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer’s Disease: An LC-MS/MS-based Metabolomics Analysis. Current Alzheimer Research 16:13, pages 1183-1195.
Crossref
Crossref
Rawan Tarawneh. (2020) Biomarkers: Our Path Towards a Cure for Alzheimer Disease. Biomarker Insights 15, pages 117727192097636.
Crossref
Crossref
Ione O.C. Woollacott, Jennifer M. Nicholas, Carolin Heller, Martha S. Foiani, Katrina M. Moore, Lucy L. Russell, Ross W. Paterson, Ashvini Keshavan, Jonathan M. Schott, Jason D. Warren, Amanda Heslegrave, Henrik Zetterberg & Jonathan D. Rohrer. (2020) Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype. Dementia and Geriatric Cognitive Disorders 49:1, pages 56-76.
Crossref
Crossref
Lijun Wang, Tianhao Gao, Tengteng Cai, Kunyi Li, Ping Zheng & Jun Liu. (2020) Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer’s disease. Neuroscience Letters 715, pages 134658.
Crossref
Crossref
Angelo Nuti, Cecilia Carlesi, Elena Caldarazzo Ienco, Gabriele Cipriani & Paolo Del Dotto. 2020. Diagnosis and Management in Dementia. Diagnosis and Management in Dementia
225
237
.
S. Bulgakova, P. Romanchuk, N. Romanchuk, V. Pyatin, D. Romanov & A. Volobuev. (2019) Alzheimer’s Disease and Artificial Intelligence: Long-term Personalized Rehabilitation and Medical and Social Support. Bulletin of Science and Practice 5:11, pages 136-175.
Crossref
Crossref
Nicola Toschi, Simone Lista, Filippo Baldacci, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Marie-Odile Habert, Bruno Dubois, Roberto Floris, Francesco Garaci, Andrea Vergallo, Harald Hampel, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, Laurie Boukadida, Nadia Boukerrou, Enrica Cavedo, Patrizia Chiesa, Olivier Colliot, Bruno Dubois, Marion Dubois, Stéphane Epelbaum, Geoffroy Gagliardi, Remy Genthon, Marie-Odile Habert, Harald Hampel, Marion Houot, Aurélie Kas, Foudil Lamari, Marcel Levy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie-Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo & Nadjia Younsi. (2019) Biomarker-guided clustering of Alzheimer's disease clinical syndromes. Neurobiology of Aging 83, pages 42-53.
Crossref
Crossref
Liu Shi, Sarah Westwood, Alison L. Baird, Laura Winchester, Valerija Dobricic, Fabian Kilpert, Shengjun Hong, Andre Franke, Abdul Hye, Nicholas J. Ashton, Angharad R. Morgan, Isabelle Bos, Stephanie J.B. Vos, Noel J. Buckley, Mara ten Kate, Philip Scheltens, Rik Vandenberghe, Silvy Gabel, Karen Meersmans, Sebastiaan Engelborghs, Ellen E. De Roeck, Kristel Sleegers, Giovanni B. Frisoni, Olivier Blin, Jill C. Richardson, Régis Bordet, José L. Molinuevo, Lorena Rami, Anders Wallin, Petronella Kettunen, Magda Tsolaki, Frans Verhey, Alberto Lleó, Daniel Alcolea, Julius Popp, Gwendoline Peyratout, Pablo Martinez‐Lage, Mikel Tainta, Peter Johannsen, Charlotte E. Teunissen, Yvonne Freund‐Levi, Lutz Frölich, Cristina Legido‐Quigley, Frederik Barkhof, Kaj Blennow, Henrik Zetterberg, Susan Baker, B. Paul Morgan, Johannes Streffer, Pieter Jelle Visser, Lars Bertram, Simon Lovestone & Alejo J. Nevado‐Holgado. (2019) Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's & Dementia 15:11, pages 1478-1488.
Crossref
Crossref
Jing Zhao, Cancan Wang, Yuanxing Zhang, Ruihua Sun, Huayuan Wang, Gai Li & Jiewen Zhang. (2019) Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis. Journal of Neuroimmunology 334, pages 577005.
Crossref
Crossref
Shuang Liang, Zijian Wang, Jiaqi Yuan, Jing Zhang, Xueling Dai, Fei Qin, Jiayu Zhang & Yaxuan Sun. (2019) Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β1-42 Induced Alzherimer’s Disease Rat Model using UHPLC-Q-Exactive Qrbitrap Mass Spectrometry. Molecules 24:14, pages 2584.
Crossref
Crossref
Paul Zeun, Rachael I. Scahill, Sarah J. Tabrizi & Edward J. Wild. (2019) Fluid and imaging biomarkers for Huntington's disease. Molecular and Cellular Neuroscience 97, pages 67-80.
Crossref
Crossref
José Luis Molinuevo, Scott Ayton, Richard Batrla, Martin M. Bednar, Tobias Bittner, Jeffrey Cummings, Anne M. Fagan, Harald Hampel, Michelle M. Mielke, Alvydas Mikulskis, Sid O’Bryant, Philip Scheltens, Jeffrey Sevigny, Leslie M. Shaw, Holly D. Soares, Gary Tong, John Q. Trojanowski, Henrik Zetterberg & Kaj Blennow. (2018) Current state of Alzheimer’s fluid biomarkers. Acta Neuropathologica 136:6, pages 821-853.
Crossref
Crossref
Harald Hampel, Sid E. O’Bryant, José L. Molinuevo, Henrik Zetterberg, Colin L. Masters, Simone Lista, Steven J. Kiddle, Richard Batrla & Kaj Blennow. (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology 14:11, pages 639-652.
Crossref
Crossref
Harald Hampel, Andrea Vergallo, Filippo Sean Giorgi, Seung Hyun Kim, Herman Depypere, Manuela Graziani, Amira Saidi, Robert Nisticò & Simone Lista. (2018) Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification. Frontiers in Neuroendocrinology 50, pages 31-51.
Crossref
Crossref
Harald Hampel, Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith L. Black, Arun L.W. Bokde, René S. Bun, Francesco Cacciola, Enrica Cavedo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Maria-Teresa Ferretti, Nathalie George, Remy Genthon, Marie-Odile Habert, Karl Herholz, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Jean Lorenceau, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Craig Ritchie, Simone Rossi, Emiliano Santarnecchi, Olaf Sporns, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Erfan Younesi, Francesco Garaci & Simone Lista. (2018) Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease 64:s1, pages S47-S105.
Crossref
Crossref
Henrik Zetterberg & Kaj Blennow. (2018) From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease. Journal of Alzheimer's Disease 64:s1, pages S271-S279.
Crossref
Crossref
Harald Hampel, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Bruno Dubois, Roberto Floris, Francesco Garaci & Simone Lista. (2018)
Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ
1–42
, total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40
. Alzheimer's & Dementia 14:4, pages 492-501.
Crossref
Crossref
Bianca A. Trombetta, Becky C. Carlyle, Aaron M. Koenig, Leslie M. Shaw, John Q. Trojanowski, David A. Wolk, Joseph J. Locascio & Steven E. Arnold. (2018) The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease. PLOS ONE 13:3, pages e0193707.
Crossref
Crossref
Nina RostgaardPeter RoosErik PorteliusKaj BlennowHenrik ZetterbergAnja H. SimonsenJørgen E. Nielsen. (2018)
CSF neurofilament light concentration is increased in presymptomatic
CHMP2B
mutation carriers
. Neurology 90:2.
Crossref
Crossref
Andrea Vergallo, Cecilia Carlesi, Cristina Pagni, Filippo Sean Giorgi, Filippo Baldacci, Lucia Petrozzi, Roberto Ceravolo, Gloria Tognoni, Gabriele Siciliano & Ubaldo Bonuccelli. (2017) A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting. Neurological Sciences 38:10, pages 1791-1797.
Crossref
Crossref